Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Australia Therapeutic Goods Administration Has Approved For Marketing Axonics' R20 Rechargeable Sacral Neuromodulation System For Overactive Bladder And Fecal Incontinence, Axonics Expects To Commence Sales Of The R20 To Australian Customers In November

Author: Benzinga Newsdesk | September 26, 2024 06:05am

Posted In: AXNX